Phytochemical Name : Caudatin

Properties Information
PhytoCAT-ID PhytoCAT-29
Phytochemical name or plant extracts Caudatin
PMID 31102888
Literature evidence BACKGROUND: The ability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to preferentially induce apoptosis in transformed cells while sparing most normal cells is well established.
IUPAC name [(3S,8S,9R,10R,12R,13S,14R,17R)-17-acetyl-3,8,14,17-tetrahydroxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate
Phytochemicals’ class or type of plant extracts Steroidal glycosides
Source of phytochemicals or plant Extracts Cynanchum auriculatum
Geographical availability China South-Central, East Himalaya, Nepal, Pakistan, Tibet, West Himalaya
Plant parts Root
Other cancers Breast cancer
Target gene or protein DR5, CHOP, p38 MAPK, JNK
Gene or Protein evidence Our results showed that caudatin sensitized breast cancer cells to TRAIL-induced apoptosis through activation of CHOP, p38 MAPK and JNK-mediated upregulation of DR5 expression.
Target pathways GR-YAP signaling pathway
IC50 NA
Potency The combination of TRAIL and caudatin may be a promising therapeutic approach for the treatment of breast cancer.
Cell line/ mice model MDA-MB-231, MCF-7/ nude mouse
Additional information  Caudatin treatment induced Ub-dependent GR degradation and blocked subsequent YAP nuclear accumulation and target gene (CTGF and CYR61) transcription signals in BCSCs. These results suggest that the GR/YAP signaling pathway regulates BCSC formation and that caudatin may be a potential anticancer agent that targets breast cancer cells and BCSCs. Caudatin inhibited breast cancer cell proliferation, mammosphere formation and tumor growth.
PubChem ID 72948694
Additional PMIDs 32570844
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:102680-1
Safety NA